<doc>
  <docmeta id="113s133is">
    <bill congress="113" type="s" number="133" version="is"/>
    <revision size="2718" annotations="0" id="4" commit-time="2013-04-18T23:21:33+00:00" committer="favila" doc="113s133is/4.xml" status="complete">
      <description/>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-Senate" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 133</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130124" legis-day="20130103">January 24
			 (legislative day, January 3), 2013</action-date>
			<action-desc>
        <sponsor name-id="S260">Mr. Roberts</sponsor> (for
			 himself, <cosponsor name-id="S301">Mr. Coburn</cosponsor>,
			 <cosponsor name-id="S317">Mr. Barrasso</cosponsor>, <cosponsor name-id="S349">Mr. Portman</cosponsor>, <cosponsor name-id="S266">Mr.
			 Crapo</cosponsor>, <cosponsor name-id="S236">Mr. Inhofe</cosponsor>, and
			 <cosponsor name-id="S299">Mr. Vitter</cosponsor>) introduced the following
			 bill; which was read twice and referred to the
			 <committee-name committee-id="SSHR00">Committee on Health, Education, Labor,
			 and Pensions</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To protect all patients by prohibiting the use of data
		  obtained from comparative effectiveness research to deny or delay coverage of
		  items or services under Federal health care programs and to ensure that
		  comparative effectiveness research accounts for advancements in personalized
		  medicine and differences in patient treatment response.</official-title>
	</form>
	<legis-body>
		<section id="idEE64EA8E0B9C45E48B60957A0ECA0C2F" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Preserving Access to Targeted,
			 Individualized, and Effective New Treatments and Services (PATIENTS) Act of
			 2013</short-title>
        </quote> or the <quote>
          <short-title>PATIENTS Act of 2013</short-title>
        </quote>.</text>
		</section>
    <section id="id518805F1C3184FBDB7E38AC1395E8308">
      <enum>2.</enum>
      <header>Prohibition on
			 Certain Uses of Data Obtained from Comparative Effectiveness Research;
			 Accounting for Personalized Medicine and Differences in Patient Treatment
			 Response</header>
			<subsection id="idFF5466E0B76E494DA4E87455130B7ADE">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">Notwithstanding any
			 other provision of law, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7500">Secretary of Health and Human Services</cato:entity-ref>—</text>
				<paragraph id="id24111E4BF57748A28D021F2CC9E1CEE5">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">shall not use data obtained from the
			 conduct of comparative effectiveness research, including such research that is
			 conducted or supported using funds appropriated under the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="American Recovery and Reinvestment Act of 2009">American Recovery and
			 Reinvestment Act of 2009</cato:entity-ref> (<cato:entity-ref entity-type="public-law" value="public-law/111/5">Public Law 111–5</cato:entity-ref>)</cato:entity> or authorized or appropriated under
			 the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Patient Protection and Affordable Care Act">Patient Protection and Affordable Care Act</cato:entity-ref> (<cato:entity-ref entity-type="public-law" value="public-law/111/148">Public Law 111–148</cato:entity-ref>)</cato:entity>, to deny or
			 delay coverage of an item or service under a Federal health care program (as
			 defined in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Social Security Act/s:1128B/ss:f">section 1128B(f) of the Social Security Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/42/1320a–7b/f">42 U.S.C.
			 1320a–7b(f)</cato:entity-ref>)</cato:entity>); and</text>
				</paragraph>
        <paragraph id="ID59a96b9809a344eaac47c81fa5319709">
          <enum>(2)</enum>
          <text>shall ensure that
			 comparative effectiveness research conducted or supported by the Federal
			 Government accounts for factors contributing to differences in the treatment
			 response and treatment preferences of patients, including patient-reported
			 outcomes, genomics and personalized medicine, the unique needs of health
			 disparity populations, and indirect patient benefits.</text>
				</paragraph>
      </subsection>
      <subsection id="id066FDF71BF284CF39CF8ABF2C6363419">
        <enum>(b)</enum>
        <header>Rule of
			 construction</header>
        <text>Nothing in this section shall be construed as
			 affecting the authority of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Commissioner of Food and Drugs</cato:entity-ref> under the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Food, Drug, and Cosmetic Act">Federal
			 Food, Drug, and Cosmetic Act</cato:entity-ref> or the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Public Health Service Act">Public Health Service Act</cato:entity-ref>.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>